Open AccessErythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines
Author(s) -
Yokoyama Maiko,
Egawa Gyohei,
Makino Takamitsu,
Egawa Kiyofumi
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2076
Subject(s) - medicine , imiquimod , regimen , dermatology , surgery , general surgery , dentistry
Key Clinical Message Development of noninvasive treatments for erythroplasia of Queyrat, a carcinoma in situ, is expected. This case suggests topical imiquimod might be a candidate with regimens consisting of much longer duration of the treatment than for genital warts and the maintenance phase of the treatment course to prevent the relapse.